Jolanda M de Vries

30PUBLICATIONS
154CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Jan 28, 2026
Countering tumor-derived PGE2-EP2/4 signaling mediates neutrophil activation.

Johanna Bödder, Robbin Kramer, Julia Minnee

|Dec 23, 2025
Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?

Imke M B van Wandeloo, Kalijn Bol, Carla van Herpen

|Nov 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva

|Jun 25, 2025
PET-based immunomapping of intratumoral CD4+ cells to monitor acquired resistance to checkpoint inhibitors.

Stefania Pezzana, Simone Blaess, Bjoern Traenkle

|May 14, 2025
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency.

Dilys D Weijers, Snežana Hinić, Emma Kroeze

Pageof 5

Frequent Collaborators

11 joint publications

Carl G Figdor

9 joint publications

Mark Aj Gorris

8 joint publications

Johannes Textor

8 joint publications

Gerty Schreibelt